RECOMBINANT CANCER THERAPEUTIC CYTOKINE
    5.
    发明公开
    RECOMBINANT CANCER THERAPEUTIC CYTOKINE 有权
    克罗地亚州克罗地亚州FÜREINE KREBSTHERAPIE

    公开(公告)号:EP3004153A4

    公开(公告)日:2016-12-21

    申请号:EP14807031

    申请日:2014-06-04

    摘要: Recombinant therapeutic cytokines (“therakines”) for the treatment of cancer are provided. The recombinant therakines include a truncated region of MDA-7/TL-24 (“M4”) not normally found in nature that has anti-cancer activity and a secretory signal which causes secretion of the therakine from plasmid/virus transduced normal and cancer cells and interaction of the therakine to MDA-7/IL-24 receptors on adjacent, neighboring and distant cancer cells. Therakine interaction results in bystander killing of the target cancer cell as well as adjacent, neighboring and distant cancer cells.

    摘要翻译: 提供了用于治疗癌症的重组治疗细胞因子(“治疗”)。 重组方法包括自然界中通常没有发现具有抗癌活性的MDA-7 / TL-24(“M4”)的截短区域,以及分泌信号,其导致质粒/病毒转导的正常和癌细胞的分泌 以及相邻的,相邻的和远处的癌细胞上的热休克蛋白与MDA-7 / IL-24受体的相互作用。 治疗相互作用导致旁观者杀死靶癌细胞以及相邻,相邻和远处的癌细胞。